We remain optimistic that Evusheld will retain its efficacy against Omicron variant
Dr Anil Kukreja, Vice President, Medical Affairs and Regulatory, AstraZeneca India, tells Akanki Sharma about Evusheld, which was…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Anil Kukreja
AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI
Benralizumab is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
AstraZeneca signs MoU with RSSDI to empower one crore Indian Diabetic patients by 2023
Chronic kidney diseases is associated with significant patient death and an increased risk of heart failure. Therefore, it is…